Literature DB >> 31584734

Home-based high-intensity interval training reduces barriers to exercise in people with type 1 diabetes.

Sam N Scott1,2, Sam O Shepherd3, Juliette A Strauss3, Anton J M Wagenmakers3, Matt Cocks3.   

Abstract

NEW
FINDINGS: What is the topic of this review? This symposium review provides an overview of the recent work investigating whether a virtually monitored home-based high-intensity interval training (Home-HIT) intervention reduces the fear of hypoglycaemia and other common barriers to exercise in people with type 1 diabetes. What advances does it highlight? Home-HIT seems to offer a strategy to reduce fear of hypoglycaemia, while simultaneously removing other known barriers that prevent people with type 1 diabetes from taking up exercise, because it is time efficient, requires no travel time or costs associated with gym memberships, and allows people to exercise in their chosen environment. ABSTRACT: People with type 1 diabetes (T1D) are recommended to engage in regular exercise for a variety of health and fitness reasons. However, many lead a sedentary lifestyle and fail to meet the physical activity guidelines, in part because of the challenge of managing blood glucose concentration and fear of hypoglycaemia. A number of strategies designed to help people with T1D to manage their blood glucose during and after exercise have been investigated. Although many of these strategies show promise in facilitating blood glucose management during and after exercise, they do not target the many other common barriers to exercise that people with T1D face, such as difficulty with cost and travel time to gyms, limited access to exercise bikes and treadmills, and a possible dislike of exercising in front of others in public places. In this symposium review, we provide an overview of ongoing research into a virtually monitored home-based high-intensity interval training (Home-HIT) programme that is designed to reduce these other common barriers to exercise. The conclusion of this review is that Home-HIT seems to offer a strategy to reduce fear of hypoglycaemia, while simultaneously removing other known barriers preventing people with T1D from taking up exercise, such as being time efficient, requiring no travel time or costs associated with gym memberships, and giving them the opportunity to exercise in their chosen environment, reducing the embarrassment experienced by some when exercising in public.
© 2019 The Authors. Experimental Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  blood glucose; exercise barriers; high-intensity interval training; home exercise; hypoglycaemia; type 1 diabetes

Year:  2019        PMID: 31584734     DOI: 10.1113/EP088097

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  4 in total

1.  Equipment-free, unsupervised high intensity interval training elicits significant improvements in the physiological resilience of older adults.

Authors:  Tanvir S Sian; Thomas B Inns; Amanda Gates; Brett Doleman; Joseph J Bass; Philip J Atherton; Jonathan N Lund; Bethan E Phillips
Journal:  BMC Geriatr       Date:  2022-06-28       Impact factor: 4.070

2.  Effects of a HIIT Protocol on Cardiovascular Risk Factors in a Type 1 Diabetes Mellitus Population.

Authors:  Jesús Alarcón-Gómez; Joaquín Calatayud; Iván Chulvi-Medrano; Fernando Martín-Rivera
Journal:  Int J Environ Res Public Health       Date:  2021-01-31       Impact factor: 3.390

3.  Effect of High-Intensity Interval Training on Quality of Life, Sleep Quality, Exercise Motivation and Enjoyment in Sedentary People with Type 1 Diabetes Mellitus.

Authors:  Jesús Alarcón-Gómez; Iván Chulvi-Medrano; Fernando Martin-Rivera; Joaquín Calatayud
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390

Review 4.  Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".

Authors:  Addisu Dabi Wake
Journal:  World J Diabetes       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.